Revolution Medicines Inc.
RVMD | NASDAQ
$188.17
-$3.14 (-1.64%)
At close: Nov 2, 2026, 4:00 PM ET
$188.01
-$0.16 (-0.09%)
After-hours:
Nov 2, 2026, 4:38 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -1.1B | -453.82M | -364.89M | -305.21M | -247.79M | -213.42M | -194.57M | -156.29M | -133.23M | -116M | -161.54M | -108.43M | -98.3M | -68.1M | -56.51M | -73.33M | -61.22M | -57.65M | -52.68M | -52.94M | -44.3M | -37.18M |
Depreciation & Amortization | 4.8M | 4.54M | 33.33M | 4.34M | 3.8M | 3.72M | 3.39M | 66K | 2.8M | 2.76M | 2.86M | 2.15M | 1.77M | 2.53M | 2.6M | 2.43M | 2.33M | 2.29M | 2.06M | 1.75M | 1.84M | 1.68M |
Stock-Based Compensation | 154.3M | 87.3M | 33.7M | 30.78M | 28.83M | 25.08M | 22.44M | 20.78M | 19.78M | 16.21M | 25.43M | 13.67M | 12.98M | 9.7M | 8.32M | 8.14M | 8.1M | 6.64M | 6.2M | 5.83M | 5.31M | 3.39M |
Other Working Capital | -23.76M | -33.8M | 42.75M | 36.9M | -13.06M | 10.71M | 13.42M | 15.92M | -660K | -19.51M | -2.16M | -1.64M | -1.43M | -2.58M | -12.36M | 1.26M | -3.76M | -7.17M | 189K | 8.47M | -274K | -2.37M |
Other Non-Cash Items | 199.48M | 24.76M | -8.61M | 6.34M | -2.3M | -12.26M | -11.57M | -8.1M | -12.77M | -16.32M | -8.47M | -5.14M | -4.85M | -3.58M | -2.17M | -1.16M | 27K | 667K | 907K | 997K | 693K | 534K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -762K | n/a | n/a | n/a | -43K | -3.87M | n/a | n/a | -419K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.87M | -16.95M | 32.25M | 56.44M | -4.3M | 2.44M | 42.78M | 13.13M | -4.74M | -47.21M | 21.2M | 1.14M | 21.28M | -2.95M | -13.6M | 12.18M | -4.95M | -7.11M | 4.25M | 7.78M | 2.37M | -5.67M |
Operating Cash Flow | -741.48M | -354.17M | -274.24M | -207.31M | -221.76M | -194.44M | -138.29M | -130.42M | -128.17M | -160.56M | -120.56M | -100.5M | -67.12M | -62.39M | -61.79M | -51.74M | -55.72M | -55.16M | -39.27M | -36.59M | -34.08M | -37.25M |
Capital Expenditures | -3.82M | -1.54M | -1.93M | -3.35M | -7.45M | -3.27M | -1.22M | -3.52M | -2.4M | -3.17M | -2.32M | -2.54M | -1.12M | -1.76M | -2.88M | -3.53M | -2.53M | -1.89M | -1.18M | -454K | -1.31M | -3.58M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 42.43M | -5.75M | 4.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -2.25B | -209.73M | -296.49M | -459.04M | -529.29M | -510.04M | -695.21M | -364.88M | -374.86M | -701.68M | -519.61M | -170.04M | -176.18M | -193.1M | -160.34M | -212.96M | -127.65M | -111.82M | -110.81M | -168.25M | -278.24M | -114.04M |
Sales Maturities Of Investments | 765.86M | 383.89M | 373.29M | 487.24M | 571.02M | 497.35M | 303.53M | 346.93M | 485.2M | 456.88M | 141.52M | 249.93M | 133.75M | 198.85M | 156.11M | 93.05M | 192.58M | 157.73M | 120.53M | 138.53M | 156.77M | 119.93M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -42.43M | 5.75M | -4.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -1.49B | 172.62M | 74.88M | 24.85M | 34.28M | -15.95M | -392.9M | -21.47M | 107.94M | -247.97M | -380.4M | 77.35M | -43.54M | 4M | -7.1M | -123.44M | 62.4M | 44.03M | 8.53M | -30.18M | -122.78M | 2.31M |
Debt Repayment | 487.07M | n/a | 244.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -743K | -252K | -244.02M | -5.74M | 250M | -18K | 284K | 3M | n/a | n/a | 836.81M | n/a | 2.58M | 499K | 1.44M | 209K | n/a | n/a | 632K | n/a | 1.43M | 555K |
Financial Cash Flow | 2.66B | 238.74M | 365.66M | -1.59M | 256.58M | 874K | 873.81M | 77.29M | 7.5M | 810K | 839.35M | 1.01M | 64.63M | 324.21M | 51.36M | 248.34M | 1.43M | 305K | 10.73M | 319K | 868K | 282.26M |
Net Cash Flow | 431.69M | 57.19M | 166.3M | -184.05M | 69.1M | -209.51M | 341.8M | -74.59M | -12.72M | -407.72M | 337.75M | -21.93M | -46.04M | 265.81M | -17.53M | 73.16M | 8.11M | -10.83M | -20M | -66.45M | -156M | 247.33M |
Free Cash Flow | -745.31M | -355.7M | -276.16M | -210.66M | -229.21M | -197.7M | -139.51M | -133.94M | -130.57M | -163.73M | -122.88M | -103.03M | -68.24M | -64.15M | -64.66M | -55.26M | -58.24M | -57.05M | -40.45M | -37.04M | -35.39M | -40.83M |
Adj. Free Cash Flow | -899.61M | -443M | -309.86M | -241.44M | -258.04M | -222.79M | -161.95M | -154.71M | -150.34M | -179.94M | -148.31M | -116.7M | -81.22M | -73.85M | -72.98M | -63.4M | -66.34M | -63.69M | -46.65M | -42.87M | -40.71M | -44.21M |
Maintenance CapEx | -3.82M | -1.54M | -1.93M | -3.35M | -7.45M | -3.27M | -1.22M | -3.52M | -2.4M | -3.17M | -2.32M | -2.54M | -1.12M | -1.76M | n/a | -983.34K | -2.05M | -1.89M | -552.24K | -454K | -1.31M | -3.58M |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.88M | -2.54M | -471.14K | n/a | -630.76K | n/a | n/a | n/a |
Owner Earnings | -745.31M | -355.7M | -276.16M | -210.66M | -229.21M | -197.7M | -139.51M | -133.94M | -130.57M | -163.73M | -122.88M | -103.03M | -68.24M | -64.15M | -61.79M | -52.72M | -57.77M | -57.05M | -39.82M | -37.04M | -35.39M | -40.83M |
Add to Watchlist
Select watchlists to add or remove RVMD